Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced ...

Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to ...

The African Union opens applications for 10 positions across various departments. See the eligibility requirements, ...

The issuer is solely responsible for the content of this announcement.

Explore why India needs region-specific antivenoms due to diverse snake venom compositions, enhancing treatment for snakebite ...